发明名称 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
摘要 Compounds 54 to 73, 75 to 79, 81 to 98, 100 to 103, 105 to 109, 111, 114 to 139, 141 to 150 as depicted are used in the manufacture of a medicament for treating neurological disease or disorders. A compound of formula I or a pharmaceutically acceptable salt or complex thereof is also used in the manufacture of a medicament for treating neurological disease or disorders. In formula (I): each X is independently Br, Cl, F, I, CF3, alkyl, OH, O-alkyl or O-acyl; each R1 is independently H, alkyl or O-acyl; each R2 is independently H, alkyl or hydroxyalkyl or both R2's together are imino; R3 is H, methyl or ethyl; R is phenoxy optionally substituted with F, Cl, Br, I, CF3, alkyl, OH, OCF3, O-alkyl or O-acyl and m is 1 to 5 provided that: i) when X is para-fluoro, R4 is not meta-CF3 substituted phenoxy; ii) when X is H then R4 is substituted with meta fluoro, meta-chloro, meta-methyl, ortho-methyl, ortho-fluoro, ortho-chloro, ortho-OH or meta-OH.
申请公布号 NZ310344(A) 申请公布日期 2001.03.30
申请号 NZ19960310344 申请日期 1996.06.07
申请人 NPC PHARMACEUTICALS, INC 发明人 MUELLER, ALAN L;MOE, SCOTT T;BALANDRIN, MANUEL F;DELMAR, ERIC G;VANWAGENEN, BRADFORD C;ARTMAN, LINDA D;BARMORE, ROBERT M;SMITH, DARYL L
分类号 C07D295/02;A61K31/135;A61K31/136;A61K31/137;A61K31/138;A61K31/155;A61K31/165;A61K31/295;A61K31/38;A61K31/381;A61K31/395;A61K31/40;A61K31/403;A61K31/404;A61K31/405;A61K31/44;A61K31/4409;A61K31/445;A61K31/4462;A61K31/4465;A61K31/451;A61K31/495;A61P25/00;A61P25/08;A61P25/28;A61P43/00;C07C211/26;C07C211/27;C07C211/28;C07C211/29;C07C211/40;C07C211/54;C07C215/28;C07C215/54;C07C217/10;C07C217/18;C07C217/26;C07C217/48;C07C217/60;C07C217/62;C07C217/72;C07C233/13;C07C233/22;C07C235/34;C07C237/22;C07C279/14;C07D207/08;C07D207/12;C07D207/20;C07D209/18;C07D209/42;C07D211/10;C07D211/18;C07D213/30;C07D213/38;C07D227/00;C07D333/20;(IPC1-7):A61K31/135;A61K31/446 主分类号 C07D295/02
代理机构 代理人
主权项
地址